Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive) (BASIC-C)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03403257 |
Recruitment Status :
Enrolling by invitation
First Posted : January 18, 2018
Last Update Posted : February 16, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Dementia Dementia Alzheimers Dementia, Vascular Dementia, Mixed | Other: No interventions |
Study Type : | Observational |
Estimated Enrollment : | 632 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive) |
Actual Study Start Date : | April 11, 2018 |
Estimated Primary Completion Date : | January 30, 2025 |
Estimated Study Completion Date : | January 30, 2025 |

Group/Cohort | Intervention/treatment |
---|---|
Subjects with cognitive impairment
Subjects with MoCA <26
|
Other: No interventions
No intervention |
Caregivers
Primary caregivers of subjects
|
Other: No interventions
No intervention |
- Prevalence of mild cognitive impairment and dementia in Mexican Americans and non Hispanic whites [ Time Frame: 2 year data collection ]Prevalence estimates
- Trajectory of cognitive function in Mexican Americans and non Hispanic whites [ Time Frame: 2 year follow-up after baseline ]Change in cognitive function among subjects entered at baseline
- Caregiver outcomes and changes over time [ Time Frame: 4 years ]Comparative caregiver outcomes among Mexican Americans and non Hispanic whites
- Needs and community available resources for cognitive impairment [ Time Frame: 2 years ]An asset map and determination of needs

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 65 Years and older (Older Adult) |
Sexes Eligible for Study: | All |
Gender Based Eligibility: | Yes |
Gender Eligibility Description: | Self-described |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- >64 years of age
- MoCA < 26
- Nueces County resident at least 6 months a year
- English or Spanish speaking
- Community dwelling or nursing home
Exclusion Criteria: none

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03403257
United States, Texas | |
Corpus Christi Nueces County Health District | |
Corpus Christi, Texas, United States, 78416 |
Principal Investigator: | Lewis Morgenstern, MD | University of Michigan |
Responsible Party: | Lewis Morgenstern, Professor, University of Michigan |
ClinicalTrials.gov Identifier: | NCT03403257 |
Other Study ID Numbers: |
R01NS100687 ( U.S. NIH Grant/Contract ) |
First Posted: | January 18, 2018 Key Record Dates |
Last Update Posted: | February 16, 2023 |
Last Verified: | February 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Plan Description: | Data sharing plan conforms to NIH rules. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Caregiving Hispanic Mexican American Epidemiology Community |
Dementia Alzheimer Disease Dementia, Vascular Brain Diseases Central Nervous System Diseases Nervous System Diseases Neurocognitive Disorders Mental Disorders Tauopathies |
Neurodegenerative Diseases Cerebrovascular Disorders Intracranial Arteriosclerosis Intracranial Arterial Diseases Leukoencephalopathies Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases Cardiovascular Diseases |